Method for resolution of citalopram intermediate 5-cyano diol
Provided is a method for resolution of formula 4-[4-dimethylamino-1-(4-fluorophenyl)-1-hydroxylbutyl]-3-hydroxy-methyl benzonitrile as an enantiomer thereof, comprising the following steps: a salt of (S)-4-[4-dimethylamino-1-(4-fluorophenyl)-1-hydroxylbutyl]-3-hydroxymethyl benzonitrile with a resolving agent D-(+)di-p-toluoyl tartaric acid was crystallized in a resolving solvent; the method is characterized in that the resolving solvent is an ether solvent. Also provided is a new crystal form of the resolved intermediate.
1. A method for resolution of 4-[4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl]-3-hydroxymethyl benzonitrile of formula I as an enantiomer thereof, comprising (a) mixing a compound of formula I and a resolving agent D-(+)di-p-toluoyl tartaric acid of formula II in a resolving solvent, (b) crystallizing a salt formed from (S)-4-[4-dimethylamino-1-(4-fluorophenyl)-1-hydroxy butyl]-3-hydroxymethyl benzonitrile of formula I′ and said resolving agent in said resolving solvent, wherein said resolving solvent is an ether solvent:
2. The method according to claim 1 , characterized in that the volume percentage of water in the ether solvent is 0.2%-10%.
3. The method according to claim 1 , characterized in that the volume percentage of water in the ether solvent is 0.2%-5%.
4. The method according to claim 1 , wherein the ether solvent is selected from the group consisting of: tetrahydrofuran, methyltetrahydrofuran, cyclopentyl methyl ether, isopropyl ether, dioxane, ethylene glycol monomethyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, diethylene glycol dimethyl ether, propylene glycol dimethyl ether and propylene glycol diethyl ether.
5. The method according to claim 2 , wherein the volume percentage of water in the ether solvent is 0.2%, 0.5%, 1.0%, 5.0% or 10.0%.